Image

Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy

Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy

Recruiting
18-90 years
All
Phase N/A

Powered by AI

Overview

As of now, although the safety of π-shaped anastomosis and the overlap method has been separately discussed in different contexts, there have been few studies considering a direct comparison of the results of these two methods.

This article aims to explore the differences in the short-term therapeutic effects, surgical effectiveness, and safety between laparoscopic total gastrectomy with esophagogastrostomy using the overlap method and the π-shaped method. The goal is to provide new reference points for surgeons in the clinical decision-making process regarding the choice of anastomotic techniques during totally laparoscopic total gastrectomy.

Eligibility

Inclusion Criteria:(1) preoperative confirmation through electronic gastroscopy and

        enhanced CT that the lesion was situated in the fundus, middle and upper third of the
        gastric body, or the entire stomach; (2) postoperative pathology confirming adenocarcinoma;
        (3) utilization of either overlap esophagojejunal anastomosis or π-shaped anastomosis in
        total laparoscopic total gastrectomy.
        -
        Exclusion Criteria:(1) patients with severe preoperative cardiac, hepatic, renal, and
        pulmonary complications; (2) preoperative neoadjuvant chemotherapy; (3) a history of
        previous abdominal surgery; (4) patients requiring combined resection due to infiltration
        of other organs during the operation; (5) patients with incomplete pathological or clinical
        data. All patients signed informed consent.
        -

Study details
    Gastric Cancer

NCT06383793

Northern Jiangsu People's Hospital

4 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.